Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing disulfides that drive the production of critically ...

Lisa Levin This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Want to build serious wealth in your 20s? Forget the fancy watches and luxury cars. Explore More: Want To Make It to the ...

The Allstate Corporation ( NYSE: ALL) Q4 2024 Earnings Call Transcript February 6, 2025 9:00 AM ET Allister Gobin - Head of Investor Relations Tom Wilson - Chair, President and Chief Executive Officer ...

And God spake unto Noah, and to his sons with him, saying, And I, behold, I establish my covenant with you, and with your seed after you; And with every living creature that is with you, of the ...

Genesis Park II LP, a significant shareholder in Redwire Corp (NYSE:RDW), has recently sold 92,694 shares of the company's common stock, according to a Form 4 filing with the Securities and ...

Redwire Corp (NYSE:RDW), a space technology company with a market capitalization of $1.58 billion, recently witnessed a notable transaction involving its common stock. Genesis Park II LP, a ...

About OTC Markets Group Inc. OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the ...

The original vehicle-to-vehicle front crash prevention test was run at 12 and 25 mph (20 and 40 kph) with a passenger car target in the center of the travel lane. It was discontinued at the end of ...

The GENESIS II Total Knee System has grown to become one of the most trusted total knee systems on the market. Cutting edge instrumentation, such as the user friendly MIS system and the ream-thru ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...